Chelsea Pinnix

Chelsea Camille Pinnix is an American oncologist who is an Associate Professor of Radiation Oncology and Director of the Residency Program at the MD Anderson Cancer Center (MDACC). Having joined the faculty 2012, her research looks to improve the outcomes of patients who suffer from lymphoma.

Pinnix attended the University of Maryland, Baltimore County for her undergraduate degree, where she studied biochemistry. She was a member of the Meyerhoff Scholarship Program. She moved to the University of Pennsylvania for her medical degree, and completed an MD-PhD in 2007. She was awarded a National Institutes of Health Medical Science Scholarship and the NIH Ruth L. Kirschstein National Research Service Award. In 2010 she was supported by the UNCF to complete postdoctoral research at the MDACC. Provided by Wikipedia
Showing 1 - 14 results of 14 for search 'Chelsea C. Pinnix', query time: 0.06s Refine Results
  1. 1
    Radiotherapy in Patients with Mycosis Fungoides and Central Nervous System Involvement

    Radiotherapy in Patients with Mycosis Fungoides and Central Nervous System Involvement by Garrett L. Jensen, Bouthaina S. Dabaja, Chelsea C. Pinnix, Jillian R. Gunther, Auris Huen, Madeleine Duvic, Yasuhiro Oki, Michelle Fanale, Chitra Hosing, Sarah A. Milgrom

    Published 2018-11-01
    Get full text
    Article
  2. 2
    Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma

    Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma by Matthew S. Ning, Chelsea C. Pinnix, Bhavana V. Chapman, Jillian R. Gunther, Sarah A. Milgrom, Joseph D. Khoury, Preetesh Jain, Wendy Y. Chen, Onyeka N. Oriabure, Maria R. Badillo, L. Michael Wang, Bouthaina S. Dabaja

    Published 2019-07-01
    Get full text
    Article
  3. 3
    Partial omission of bleomycin for early‐stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?

    Partial omission of bleomycin for early‐stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes? by Jillian R. Gunther, Chelsea C. Pinnix, Gordon R. Glober, Kaitlin M. Christopherson, Penny Fang, Hun Ju Lee, Sairah Ahmed, Raphael E. Steiner, Ranjit Nair, Paolo Strati, Sattva S. Neelapu, Loretta J. Nastoupil, Bouthaina S. Dabaja

    Published 2020-07-01
    Get full text
    Article
  4. 4
    Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphoma

    Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphoma by Raphael E. Steiner, Jose Banchs, Efstratios Koutroumpakis, Melody Becnel, Cristina Gutierrez, Paolo Strati, Chelsea C. Pinnix, Lei Feng, Gabriela Rondon, Catherine Claussen, Nicolas Palaskas, Kaveh Karimzad, Sairah Ahmed, Sattva S. Neelapu, Elizabeth Shpall, Michael Wang, Francisco Vega, Jason Westin, Loretta J. Nastoupil, Anita Deswal

    Published 2021-11-01
    Get full text
    Article
  5. 5
    Mitigating Bias in Recruitment: Attracting a Diverse, Dynamic Workforce to Sustain the Future of Radiation Oncology

    Mitigating Bias in Recruitment: Attracting a Diverse, Dynamic Workforce to Sustain the Future of Radiation Oncology by Meriem Mokhtech, MD, Reshma Jagsi, MD, DPhil, FASTRO, Raymond Mailhot Vega, MD, MPH, Derek W. Brown, PhD, Daniel W. Golden, MD, MHPE, Titania Juang, PhD, Malcolm D. Mattes, MD, Chelsea C. Pinnix, MD, PhD, Suzanne B. Evans, MD, MPH

    Published 2022-11-01
    Get full text
    Article
  6. 6
    New paradigm for radiation in multiple myeloma: lower yet effective dose to avoid radiation toxicity

    New paradigm for radiation in multiple myeloma: lower yet effective dose to avoid radiation toxicity by Adnan Elhammali, Behrang Amini, Ethan B. Ludmir, Jillian R. Gunther, Sarah A. Milgrom, Chelsea C. Pinnix, Therese Andraos, Alison Yoder, Donna Weber, Robert Orlowski, Elisabet Manasanch, Krina Patel, Paolo Strati, Ranjit Nair, Hans C. Lee, Sheeba Thomas, Swaminathan Iyer, Gregory Kaufmann, Naveen Garg, Bouthaina S. Dabaja

    Published 2020-07-01
    Get full text
    Article
  7. 7
    Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions

    Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions by Chelsea C. Pinnix, MD, PhD, Therese Y. Andraos, MD, Bouthaina Dabaja, MD, Sarah Milgrom, MD, Grace Smith, MD, PhD, Dai Chihara, MD, PhD, Andrea Ng, MD, Luis E. Fayad, MD, Yasuhiro Oki, MD, Sattva Neelapu, MD, Jason Westin, MD, M. Alma Rodriguez, MD, Loretta J. Nastoupil, MD

    Published 2017-07-01
    Get full text
    Article
  8. 8
    The Fletcher-Cox Pathway: A Unique View on Clinical Trial Education

    The Fletcher-Cox Pathway: A Unique View on Clinical Trial Education by Shalini Moningi, MD, Shane Stecklein, MD, PhD, Sonal Noticewala, MD, MAS, Olsi Gjyshi, MD, Todd Pezzi, MD, David Boyce-Fappiano, MD, Prajnan Das, MD, MS, MPH, Bruce Minsky, MD, Emma B. Holliday, MD, Andrew J. Bishop, MD, Albert C. Koong, MD, PhD, Chelsea C. Pinnix, MD, PhD

    Published 2024-12-01
    Get full text
    Article
  9. 9
    Outcomes and toxicities in patients with diffuse-large B cell lymphoma involving the gastrointestinal tract and digestive organs

    Outcomes and toxicities in patients with diffuse-large B cell lymphoma involving the gastrointestinal tract and digestive organs by Gohar S. Manzar, Elaine E. Cha, Kelsey L. Corrigan, Alison K. Yoder, Benjamin R. Schrank, Lewis F. Nasr, Dai Chihara, Luis Malpica Castillo, Ranjit Nair, Preetesh Jain, Sattva S. Neelapu, Maria A. Rodriguez, Paolo Strati, Loretta J. Nastoupil, Jillian R. Gunther, Bouthaina S. Dabaja, Chelsea C. Pinnix, Susan Y. Wu, Penny Q. Fang

    Published 2024-09-01
    Get full text
    Article
  10. 10
    Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas

    Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas by Gohar S. Manzar, Chelsea C. Pinnix, Stephanie O. Dudzinski, Kathryn E. Marqueen, Elaine E. Cha, Lewis F. Nasr, Alison K. Yoder, Michael K. Rooney, Paolo Strati, Sairah Ahmed, Chijioke Nze, Ranjit Nair, Luis E. Fayad, Michael Wang, Loretta J. Nastoupil, Jason R. Westin, Christopher R. Flowers, Sattva S. Neelapu, Jillian R. Gunther, Bouthaina S. Dabaja, Susan Y. Wu, Penny Q. Fang

    Published 2025-01-01
    Get full text
    Article
  11. 11
    Positron emission tomography–computed tomography predictors of progression after DA-R-EPOCH for PMBCL

    Positron emission tomography–computed tomography predictors of progression after DA-R-EPOCH for PMBCL by Chelsea C. Pinnix, Andrea K. Ng, Bouthaina S. Dabaja, Sarah A. Milgrom, Jillian R. Gunther, C. David Fuller, Grace L. Smith, Zeinab Abou Yehia, Wei Qiao, Christine F. Wogan, Mani Akhtari, Osama Mawlawi, L. Jeffrey Medeiros, Hubert H. Chuang, William Martin-Doyle, Philippe Armand, Ann S. LaCasce, Yasuhiro Oki, Michelle Fanale, Jason Westin, Sattva Neelapu, Loretta Nastoupil

    Published 2018-06-01
    Get full text
    Article
  12. 12
    Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma

    Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma by Susan Y. Wu, MD, Penny Q. Fang, MD, MBA, Ethan B. Wang, BA, Sairah Ahmed, MD, Madeleine Duvic, MD, Preetesh Jain, MD, Luis E. Malpica Castillo, MD, Ranjit Nair, MD, Raphael E. Steiner, MD, Paolo Strati, MD, Auris O. Huen, MD, PharmD, Swaminathan P. Iyer, MD, Chelsea C. Pinnix, MD, PhD, Bouthaina S. Dabaja, MD, Jillian R. Gunther, MD, PhD

    Published 2023-11-01
    Get full text
    Article
  13. 13
    Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type: A Role for Elective Nodal Irradiation?

    Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type: A Role for Elective Nodal Irradiation? by Penny Fang, MD, MBA, Sonal S. Noticewala, MD, Susan Y. Wu, MD, Jillian R. Gunther, MD, PhD, Ethan B. Ludmir, MD, L. Jeffrey Medeiros, MD, Paolo Strati, MD, Ranjit Nair, MD, Chijioke Nze, MD, Loretta J. Nastoupil, MD, Sairah Ahmed, MD, Luis Malpica Castillo, MD, Luis Fayad, MD, Jason Westin, MD, Sattva Neelapu, MD, Christopher Flowers, MD, Auris Huen, MD, Swaminathan P. Iyer, MD, Bouthaina Dabaja, MD, Chelsea C. Pinnix, MD, PhD

    Published 2024-12-01
    Get full text
    Article
  14. 14
    Ultra–Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung

    Ultra–Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung by Susan Y. Wu, MD, Penny Q. Fang, MD, MBA, Ahmed Fetooh, MBBS, Gohar S. Manzar, MD, PhD, Kelsey L. Corrigan, MD, MPH, Benjamin R. Schrank, MD, PhD, Lewis Nasr, MD, MS, Dai Chihara, MD, PhD, Luis E. Malpica Castillo, MD, Ranjit Nair, MD, Raphael E. Steiner, MD, Preetesh Jain, MBBS, MD, DM, PhD, Sattva S. Neelapu, MD, Paolo Strati, MD, Loretta J. Nastoupil, MD, Bouthaina S. Dabaja, MD, Chelsea C. Pinnix, MD, PhD, Jillian R. Gunther, MD, PhD

    Published 2024-12-01
    Get full text
    Article

Search Tools: